Posts Tagged ‘ Biosimilar ’

Strategies for commercial success of biosimilars - 19 April 2012

Whilst biopharmaceuticals remain a major component of the global therapeutics market, the ever expanding portfolio of products losing patent protection and with increasing healthcare costs remaining a poignant issue, the opportunity for development of competing, follow on biologics remains an attractive proposition for both Biotech and Pharma companies alike. This Euroscicon biosimilars conference...

testimonials

‘It was a pleasure to chair the meeting, I am not just paying lip service either, the delegates were very enthusiastic, in fact we put an impromptu sessions on nanoparticles into the lunch time break, this was a request generated by the delegates, so I was very impressed, it was very well organised and I felt my time was very well spent’ - Ian Dimmick, Newcastle University, UK

‘Thank you for giving me the opportunity to speak at your meeting yesterday. It was a very interesting meeting and provided a great opportunity to exchange ideas among investigators in the innate immunity/TLR field’. Dr Michael Carty, Trinity College Dublin

‘I thoroughly enjoyed the meeting’.Professor Neil Gow, University of Aberdeen , UK

‘Many thanks for your email and delegate list - it was a most enjoyable and informative meeting’ Professor John Gallagher, The Paterson Institute for Cancer Research, Manchester, UK

‘ It was jolly good meeting/ Look forward to recieving the proceedings and also the e-mails and addresses of the participants. This meeting aroused my old itchings for revisiting some unfinished science’.Professor PK Das, University of Amsterdam, Holland

‘It was an interesting event indeed with some follow up for my group - a possible collaboration.….I did enjoy the meeting very much’- Dr NinoPorakishvili, University of Westminster, UK

‘I thought the lecture theatre was superb and the organisation was top notch.’ Steven Jones, DakoCytomation Ltd, UK

‘Thanks for a delightful and interesting meeting. I think it worked just great with the mix of academic and company-based presentations and the whole program felt comprehensive and important’ - Fredrik Ponten, MD, PhD Department of Genetics and Pathology, Uppsala University, HPR research group, Sweden

‘I enjoyed the scientific aspects of the conference also the opportunity of meeting so many delegates in our field’ Professor Ten Feizi, Director, Glycosciences Laboratory, Imperial College London, UK

‘Thank you for the opportunity to speak, which I hope was interesting for the majority of the audience. I would like to say that the organistion of the event was excellent’ Andy Sutcliffe, Procognia Ltd,UK

‘A big thanks to you and all your team for putting on the excellent meeting yesterday. The meeting place was great, and the organisation was superb. No hitches at all from my point of view. From the conversations I had with some of the delegates, it seems that the meeting was well received. There really is no other regular forum for these kinds of discussions in the UK , so it was a very welcome opportunity’.- Professor. Julian Ma , Hotung Chair of Molecular Immunology, Dept. of Cellular and Molecular Medicine (CMM), St. George \'s Hospital Medical School, London

‘A civilised exchange of views on differences in findings – clear presentations’ - Jan Clark, CIMR

‘I thought the day was successful. I would be interested in doing something similar again’ Kind regards Professor Andrew Peters - Director of ARPEXAS Ltd, University of Nottingham, UK

‘Liked the fact the speakers were available to answer questions during the coffee time. It was useful having the companies give seminars as opposed to just having them at their stand’- Sarah Burl, Infant Immunology Group, Virology Department, MRC The Gambia

‘Thoroughly enjoyed the meeting last week - just such a shame that I could not stay for the whole day - but what I did hear was very interesting. I certainly will come to more of the events as some of the titles on the programme look really good’ - Professor Diana Watt, Professor of Human Anatomy, Brighton and Sussex Medical School, UK

‘We enjoyed the day very much indeed and look forward to attending another event soon’.- Scott Reid. IAH Pirbright, Institute for Animal Health

‘Good location, staff very helpful, Tony Warford entertaining and knowledgeable chairman’ - Pauline Connor, North Middlesex Hospital , London

‘Thank you for organising such a useful meeting. I know that it was apprecaited by many colleagues and that it provoked good discussion and scientific debate’ - Dr Paul Duprex, School of Biomedical Sciences, The Queen\'s University of Belfast, Ireland

‘Well organised, interesting speakers were chosen’ - Philippa Roddam, St Jude Children\'s Research Hospital , Memphis, USA

‘Very high quality talks and speakers’-Joanna Bridger PhD, Senior L ec turer, Centre for Cell and Chromosome Biology, Biosciences, Brunel University

‘I enjoyed the meeting, the duration of each of the speakers was just right and was pitched at just the right level for the audience. Great forum for meeting people and discussing the subject matter, overall very informative’ - Vivien Jacobs, AstraZenea

‘I have found the talks very stimulating. The content was of high standard . A well run and presented meeting ’.- Mrs Jean Bettany, Smith & Nephew, UK

‘Good range of talks – very interesting and relevant’ - Dr Lorna Jarvis , Addenbrooke\'s Hospital, Cambridge, UK

Euroscicon News

Meeting announcement: Molecular Pharming – recent progress in manufacturing medicines in plants
Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europ […]
Job: Microbiology Manager
As Microbiology Manager you are responsible for managing the transfer, application, qualification and validation of microbiological methodologies for, in-process and QC batch release and stability testing of a wide range of potential biopharmaceutical products. […]